Cargando…

Ethacridine inhibits SARS-CoV-2 by inactivating viral particles

The respiratory disease COVID-19 is caused by the coronavirus SARS-CoV-2. Here we report the discovery of ethacridine as a potent drug against SARS-CoV-2 (EC(50) ~ 0.08 μM). Ethacridine was identified via high-throughput screening of an FDA-approved drug library in living cells using a fluorescence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaoquan, Lidsky, Peter V., Xiao, Yinghong, Wu, Chien-Ting, Garcia-Knight, Miguel, Yang, Junjiao, Nakayama, Tsuguhisa, Nayak, Jayakar V., Jackson, Peter K., Andino, Raul, Shu, Xiaokun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445489/ https://www.ncbi.nlm.nih.gov/pubmed/34478458 http://dx.doi.org/10.1371/journal.ppat.1009898

Ejemplares similares

Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models
por: Li, Xiaoquan, et al.
Publicado: (2020)

Variability in viral pathogenesis: modeling the dynamic of acute and persistent infections
por: Lidsky, Peter V, et al.
Publicado: (2017)

SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming
por: Wu, Chien-Ting, et al.
Publicado: (2023)

SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
por: Wu, Chien-Ting, et al.
Publicado: (2021)

Spectrophotometric determination of ethacridine lactate in infusion
por: Jain, Pritam S., et al.
Publicado: (2011)

Epidemics as an adaptive driving force determining lifespan setpoints
por: Lidsky, Peter V., et al.
Publicado: (2020)

Glycolysis and the Hexosamine Biosynthetic Pathway as Novel Targets for Upper and Lower Airway Inflammation
por: Kim, Young Hyo, et al.
Publicado: (2018)

Introduction of Dicistrovirus IRESs into UAS/SV40-polyA constructs results in premature polyadenylation and strong overexpression of the upstream ORF in Drosophila animals
por: Lidsky, Peter V., et al.
Publicado: (2023)

Is Aging an Inevitable Characteristic of Organic Life or an Evolutionary Adaptation?
por: Lidsky, Peter V., et al.
Publicado: (2023)

Antibacterial Properties of Ethacridine Lactate and Sulfmethoxazole Loaded Functionalized Graphene Oxide Nanocomposites
por: Jabri, Tooba, et al.
Publicado: (2023)

A defective viral genome strategy elicits broad protective immunity against respiratory viruses
por: Xiao, Yinghong, et al.
Publicado: (2021)

SARS-CoV-2 Nsp1 regulates translation start site fidelity to promote infection
por: Aviner, Ranen, et al.
Publicado: (2023)

Development and validation of RP-HPLC method for estimation of ethacridine lactate in bulk and in pharmaceutical formulation
por: Jain, P. S., et al.
Publicado: (2011)

Monitoring integrated stress response in live Drosophila
por: Lidsky, Peter V., et al.
Publicado: (2023)

Encapsulation of Saccharomyces pastorianus Residual Biomass in Calcium Alginate Matrix with Insights in Ethacridine Lactate Biosorption
por: Rusu, Lăcrămioara, et al.
Publicado: (2022)

Mifepristone combined with ethacridine lactate for third-trimester stillbirth induction: a 5-year experience from Shanghai
por: Xue, Rui-Hong, et al.
Publicado: (2022)

Efficacy of combination of localized closure, ethacridine lactate dressing, and phototherapy in treatment of severe extravasation injuries: A case series
por: Lu, Yan-Xu, et al.
Publicado: (2021)

ATM-SPARK: A GFP phase separation–based activity reporter of ATM
por: Li, Xiaoquan, et al.
Publicado: (2023)

Biosorptive Removal of Ethacridine Lactate from Aqueous Solutions by Saccharomyces pastorianus Residual Biomass/Calcium Alginate Composite Beads: Fixed-Bed Column Study
por: Rusu, Lăcrămioara, et al.
Publicado: (2022)

Viral polymerases
por: Menéndez-Arias, Luis, et al.
Publicado: (2017)

Effect of Bathing in a 0.1% Aqueous Solution of Ethacridine Lactate on Selected Physiological Parameters of Cornu Aspersum Müller Edible Snails
por: Ziętek, Jerzy, et al.
Publicado: (2020)

Viral Evolution: It Is All About Mutations
por: Stern, Adi, et al.
Publicado: (2016)

Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding
por: Lin, Chien-Ju, et al.
Publicado: (2018)

Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers
por: Nakayama, Tsuguhisa, et al.
Publicado: (2021)

Chemogenetic Minitool for Dissecting the Roles of Protein Phase Separation
por: Chung, Chan-I, et al.
Publicado: (2023)

SARS-CoV-2 entry factors are expressed in nasal, ocular, and oral tissues: implications for COVID-19 prophylaxes/therapeutics
por: Lee, Ivan, et al.
Publicado: (2021)

Targeting Nup358/RanBP2 by a viral protein disrupts stress granule formation
por: Sadasivan, Jibin, et al.
Publicado: (2022)

Capture and inactivation of viral particles from bioaerosols by electrostatic precipitation
por: Preston, Hannah E., et al.
Publicado: (2023)

Editorial overview: Viral pathogenesis: Strategies for virus survival — Acute versus persistent infections
por: Andino, Raul, et al.
Publicado: (2017)

Inactivated Viral Vaccines
por: Sanders, Barbara, et al.
Publicado: (2014)

Viral inactivation by light
por: Sadraeian, Mohammad, et al.
Publicado: (2022)

Spying on SARS-CoV-2 with Fluorescent Tags and Protease Reporters
por: To, Tsz-Leung, et al.
Publicado: (2023)

Type I interferon responsive microglia shape cortical development and behavior
por: Escoubas, Caroline C., et al.
Publicado: (2023)

Mediators of Allergic Asthma and Rhinosinusitis
por: Kim, Young Hyo, et al.
Publicado: (2017)

Microcurrent technology for rapid relief of sinus pain: a randomized, placebo‐controlled, double‐blinded clinical trial
por: Maul, Ximena A., et al.
Publicado: (2019)

Characterization and mutagenesis of Chinese hamster ovary cells endogenous retroviruses to inactivate viral particle release
por: Duroy, Pierre‐Olivier, et al.
Publicado: (2019)

Viral inactivation by irradiation rays
por: Liu, Kai-Kai, et al.
Publicado: (2023)

Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles
por: Cheng, Hua-Yew, et al.
Publicado: (2011)

A tradeoff between enterovirus A71 particle stability and cell entry
por: Catching, Adam, et al.
Publicado: (2023)

Photothermal inactivation of universal viral particles by localized surface plasmon resonance mediated heating filter membrane
por: Yoo, Seunghwan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rd8626v18o9bi2db7a0sotv83a